Accelerating Preclinical Safety with Connected Data and Predictive Insights
Enhancing Study Quality and Data Integrity in the Preclinical Phase
Unifying Science and Safety to Navigate the Iterative Path of Lead Optimization
Discover how Instem’s Advance™, Predict™, and BioRails® accelerate early-stage drug discovery by unifying in silico insights, experimental data, and streamlined workflows.
With integrated, insight‑driven platforms that cut through data complexity and eliminate fragmented workflows, Instem empowers researchers to reduce risk, boost efficiency, and accelerate the journey from discovery to IND submission.
NAMs have the potential to deliver more efficient safety assessments, enabling faster and more confident development decisions while also supporting more ethical drug development.
